Dr. Jonathan Sive is a Consultant Haematologist and Clinical Service Lead for Myeloma. He is highly experienced in both the diagnosis and management of blood cancers, particularly in myeloma and other plasma cell disorders such as MGUS, plasmacytomas, and POEMS Syndrome. He also has expertise in the investigation of anaemia and other abnormal blood counts. He is an executive member of the UK Myeloma Forum where he coordinates myeloma management and guidelines at a national level. He is the lead author of the recently published UK national guidelines on the diagnosis and initial treatment of myeloma. He is also an active member of the UK Myeloma Research Alliance, where he is involved in the planning and management of national clinical trials. Dr. Sive completed his specialist haematology training and carried out a PhD in Molecular Haematology at Cambridge University, for which he was awarded a Cancer Research UK Clinical Fellowship. He remains actively engaged in a variety of clinical research projects, and his work has been widely published in peer-reviewed journals and textbooks. Dr. Sive is committed to improving outcomes and well-being for his patients and combines professional, expert advice with a caring and sympathetic manner. He is registered as a provider with all major UK insurance companies and is also happy to see uninsured self-pay patients. His areas of expertise include the investigation and treatment of myeloma, management of other plasma cell abnormalities such as MGUS, plasmacytomas, and POEMS Syndrome, and the investigation and management of anaemia and other blood count abnormalities.